Ligand Pharmaceuticals Inc (LGND)
86.01
+0.99
(+1.16%)
USD |
NASDAQ |
May 17, 16:00
86.01
0.00 (0.00%)
After-Hours: 16:23
Ligand Pharmaceuticals Max Drawdown (5Y): 77.41% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 77.41% |
March 31, 2024 | 77.41% |
February 29, 2024 | 77.41% |
January 31, 2024 | 77.41% |
December 31, 2023 | 77.41% |
November 30, 2023 | 77.41% |
October 31, 2023 | 77.41% |
September 30, 2023 | 77.41% |
August 31, 2023 | 77.41% |
July 31, 2023 | 77.41% |
June 30, 2023 | 77.41% |
May 31, 2023 | 77.41% |
April 30, 2023 | 77.41% |
March 31, 2023 | 77.41% |
February 28, 2023 | 77.41% |
January 31, 2023 | 77.41% |
December 31, 2022 | 77.41% |
November 30, 2022 | 77.41% |
October 31, 2022 | 76.91% |
September 30, 2022 | 76.91% |
August 31, 2022 | 76.91% |
July 31, 2022 | 76.91% |
June 30, 2022 | 76.91% |
May 31, 2022 | 76.91% |
April 30, 2022 | 76.91% |
Date | Value |
---|---|
March 31, 2022 | 76.91% |
February 28, 2022 | 76.91% |
January 31, 2022 | 76.91% |
December 31, 2021 | 76.91% |
November 30, 2021 | 76.91% |
October 31, 2021 | 76.91% |
September 30, 2021 | 76.91% |
August 31, 2021 | 76.91% |
July 31, 2021 | 76.91% |
June 30, 2021 | 76.91% |
May 31, 2021 | 76.91% |
April 30, 2021 | 76.91% |
March 31, 2021 | 76.91% |
February 28, 2021 | 76.91% |
January 31, 2021 | 76.91% |
December 31, 2020 | 76.91% |
November 30, 2020 | 76.91% |
October 31, 2020 | 76.91% |
September 30, 2020 | 76.91% |
August 31, 2020 | 76.91% |
July 31, 2020 | 76.91% |
June 30, 2020 | 76.91% |
May 31, 2020 | 76.91% |
April 30, 2020 | 76.91% |
March 31, 2020 | 76.91% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
61.41%
Minimum
May 2019
77.41%
Maximum
Nov 2022
75.38%
Average
76.91%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
ANI Pharmaceuticals Inc | 72.96% |
Annovis Bio Inc | -- |
ADMA Biologics Inc | 84.77% |
United Therapeutics Corp | 60.30% |
Blueprint Medicines Corp | 69.50% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -23.37 |
Beta (5Y) | 0.9178 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 55.04% |
Historical Sharpe Ratio (5Y) | -0.2388 |
Historical Sortino (5Y) | -0.5183 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 20.20% |